期刊文献+

微生态制剂双歧杆菌三联活菌散综合治疗新生儿黄疸的临床疗效

Clinical effect of probiotic Bifidobacterium triple viable bacteria powder in the treatment of neonatal jaundice
原文传递
导出
摘要 目的 探讨微生态制剂双歧杆菌三联活菌散综合治疗新生儿黄疸的临床疗效.方法 随机选取2020年10月-2021年10月期间60例黄疸新生儿,按照随机数字表法将这些患儿分成观察组和对照组,每组均30例,对照组使用蓝光等常规治疗;观察组在以上基础上使用双歧杆菌三联活菌散治疗.治疗前后分别采集两组患儿血液以检测血清总胆红素(total serum bilirubin,TSB)水平;记录两组患儿黄疸消退时间和住院时间.比较两组临床治疗效果和不良反应.结果 两组患儿治疗后TSB平均水平较治疗前明显降低,观察组患儿治疗后TSB水平平均为(68.36±2.25)umol/L,低于对照组平均水平(107.85±6.23)umol/L,P<0.05.观察组患儿黄疸消退平均时间和平均住院时间均短于对照组,P<0.05.观察组治疗显效率为83.33%,高于对照组的治疗显效率60.0%,P<0.05.两组治疗期间未见严重不良反应.结论 微生态制剂双歧杆菌三联活菌散综合治疗新生儿黄疸患儿疗效显著且不会增加不良反应,具有推广价值. 0bjective To invesigate the clinical effect of probiotic Bifidobacterium triple viable bacteria powder in the treatment of neonatal jaundice Methods A total of 60 neconates with jaundice from October 2020 to October 2021 were randomly selected and divided into an observation group and a control group according to the random number table method,with 30 cases in each group.The control group received conventional treatment methods such as blue light et al;the observation group was treated with probiotic Bifidobacterium triple viable bacteria powder on the basis of the above.Before and after treatment,blood was collected from the two groups of children to detect total serum bilirubin(TSB) levels;jaundice subsided time and hoepital stay were recorded in two groupe.The clinical therapeutic effects and adverse reactions were compared bewveen the two groups.Results The average level of TSB in the two groups after treatment was significatnly lower than that before treatment.The average level of TSB in the observation group after treatment was(68.36±2.25)umol/L,which was lower than the avenage level in the control group(107.85±6.23)umol/L,P<0.05.The mean time of joundice subsidence and the mean hospital stay of children in the observation group were shorter than those in the control group,P<0.05.The effective rate of the obsevation group was 83.33% higher than that of the conlrol goup,which was 60.0%,P<0.05.No serious advese reactions were observed in the two groups during treatment.Conclusion Probiotic preparation Bifidobacterium triple viable bacteria powder has a significant curative effect in the comprehensive treatment of neonatal jaundice children without inereasing side effects,and has promotion value.
作者 邓秋秋 Deng Qiuqiu(Changsha Third Hospital,Pediatrics,Changsha,Hunan 410000)
机构地区 长沙市第三医院
出处 《首都食品与医药》 2022年第14期48-50,共3页 Capital Food Medicine
关键词 血清总胆红素 新生儿黄疸 双歧杆菌三联活菌散 蓝光 serum total bilirubin neonatal jaundice bifidobacteria triple viable bacteria powder blue light
  • 相关文献

参考文献7

二级参考文献96

  • 1樊明方.茵栀黄治疗新生儿黄疸疗效观察[J].实用中医药杂志,2007,23(1):9-9. 被引量:14
  • 2薛辛东.新生儿溶血病//沈晓明,王卫平.儿科学.7版.北京:人民卫生出版社,2008:118.
  • 3中华医学会.临床诊断指南小儿内科分册.新生儿黄疸.北京:人民卫生出版杜,2005:55-60.
  • 4卫生部.母婴ABO血型不合溶血病临床路径(2009年版).
  • 5中华医学会.临床技术操作规范儿科学分册.北京:人民军医出版社,2000:88.
  • 6Guyatt GH,Haynes RB,Jaeschke RZ. Users’ guides to the medical literature,XXV:evidence-based medicine:principles for applying the users'guides to patient care. Evidence-Based medicine working group[J].{H}JAMA:the Journal of the American Medical Association,2000,(10):1290-1296.
  • 7McClave SA,Martindale RG,Vanek VW. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine(SCCM)and American Society for Parenteral and Enteral Nutrition(A.S.P.E.N.)[J].{H}JPEN Journal of Parenteral and Enteral Nutrition,2009,(3):277-316.
  • 8Kleinman RE. Feeding the infant[A].Elk Grove Village,IL:American Aca-demy of Pediatrics,2008.3-144.
  • 9American Society for Parenteral and Enteral Nutrition(A.S.P.E.N.)Board of Directors. Clinical guidelines for the use of parenteral and en-teral nutrition in adult and pediatric patients,2009[J].{H}JPEN Journal of Parenteral and Enteral Nutrition,2009,(3):255-259.
  • 10Behrman RE,Kliegman RM,Jenson HB. Nelson textbook of pediatrics 17th ed.Copyright[M].Elsevier Science(USA),2004.159.

共引文献411

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部